(Q36694292)
Statements
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours (English)
F M Wachters
H J M Groen
J G Maring
M Porro
H Dumez
A T van Oosterom
1 June 2004
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference